How serious is FDA warning about revolutionary blood-cancer

Dana-Farber Cancer Institute researcher details promise, peril of CAR T-cell therapy, which enlists body’s immune system to fight disease.

Lyfgenia and Casgevy Become First FDA-Approved Gene Therapies for Sickle Cell Disease - Xtalks

Mark Flower on LinkedIn: #isctna2023 #celltherapy #allogeneic #nkcells #cordblood

ICancer Event

Used Book in Good Condition Highlight, take notes, and search in the book

Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer

FDA warns against widely used ovarian cancer screening test

James Wang, PhD on LinkedIn: Kite releases pivotal CAR T therapy Phase III study results

Mark Flower on LinkedIn: Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for…

News and Opinions - World Stem Cell Summit

Mark Flower on LinkedIn: Liso-cel Earns European Approval for Relapsed/Refractory LBCL After 1…

Living Medicine: Don Thomas, Marrow Transplantation, and the Cell Therapy Revolution: Appelbaum M.D., Frederick: 9798887700151: : Books

FDA investigates CAR-T therapy as causing cancer in rare cases

Oncology/Hematology Leukemiaarticles page [1]